Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

71.96
Delayed Data
As of Aug 18
 +2.09 / +2.99%
Today’s Change
16.61
Today|||52-Week Range
99.45
+62.00%
Year-to-Date

Today’s Trading

Previous close69.87
Today’s open69.55
Day’s range68.50 - 74.74
Volume1,903,715
Average volume (3 months)1,837,345
Market cap$3.5B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+7.35%
Earnings growth (this year)+20.63%
Earnings growth (next 5 years)-84.45%
Revenue growth (last year)--
P/E ratioNM
Price/Sales21,912.70
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.03+0.08%
OPKOPKO Health Inc+0.24+4.08%
ACADACADIA Pharmaceutica...+0.05+0.16%
PTLAPortola Pharmaceutic...+0.77+1.45%
Data as of 4:01pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.20
Annual revenue (last year)$78.0K
Annual profit (last year)-$349.1M
Net profit margin-447,611.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Patrick J. Mahaffy
SVP-Finance, Chief Financial &
Accounting Officer
Daniel W. Muehl
Corporate headquarters
Boulder, Colorado

Forecasts